NSAIDs relieve dysmenorrhea primarily by inhibiting which enzyme involved in prostaglandin synthesis?

Prepare effectively for the Physician Assistant Clinical Knowledge Rating and Assessment Tool (PACKRAT) 1 Exam with comprehensive resources, flashcards, and detailed explanations. Ace your test with ease!

Multiple Choice

NSAIDs relieve dysmenorrhea primarily by inhibiting which enzyme involved in prostaglandin synthesis?

Explanation:
NSAIDs relieve dysmenorrhea by blocking cyclooxygenase, the enzyme that converts arachidonic acid into prostaglandins responsible for uterine contractions and pain. By inhibiting cyclooxygenase, prostaglandin production drops, leading to reduced uterine tone and cramping. The lipoxygenase pathway makes leukotrienes, which are not the primary drivers of menstrual cramps, so inhibiting it isn’t the main action of NSAIDs. Activating prostacyclin synthase would raise a different prostaglandin (PGI2) and isn’t how NSAIDs produce analgesia. Blocking leukotriene receptors targets leukotrienes rather than prostaglandins, so it doesn’t explain NSAID effects on dysmenorrhea.

NSAIDs relieve dysmenorrhea by blocking cyclooxygenase, the enzyme that converts arachidonic acid into prostaglandins responsible for uterine contractions and pain. By inhibiting cyclooxygenase, prostaglandin production drops, leading to reduced uterine tone and cramping. The lipoxygenase pathway makes leukotrienes, which are not the primary drivers of menstrual cramps, so inhibiting it isn’t the main action of NSAIDs. Activating prostacyclin synthase would raise a different prostaglandin (PGI2) and isn’t how NSAIDs produce analgesia. Blocking leukotriene receptors targets leukotrienes rather than prostaglandins, so it doesn’t explain NSAID effects on dysmenorrhea.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy